Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental rat

References

• Amber KT, Bloom R, Mrowietz U, Hertl M. 2015. TNF-α: a treatment target or cause of sarcoidosis? J Eur Acad Dermatol Venereol. 29:2104–2111.
   PubMed Web of Science ®Google Scholar
• Andronescu CI, Purcarea MR, Babes PA. 2018. Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications. J Med Life. 11:20–23.
   PubMedGoogle Scholar
• Cao LJ, Miao J, Liu JX, Gao WY, Li X. 2015. Research on contents of anthraquinones in Cassiae semen by principal component analysis. Zhongguo Zhong Yao Za Zhi. 40:2589–2593.
   PubMedGoogle Scholar
• Carabelli J, Burgueno AL, Rosselli MS, Gianotti TF, Lago NR, Pirola CJ, Sookoian S. 2011. High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia. J Cell Mol Med. 15:1329–1338.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. 2012. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 55:2005–2023.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang X, Zhang J, Gao Y, Yang Z, Li S, Dai H. 2017. Attenuation of acute lung injury in a rat model by semen Cassiae. BMC Complem Altern Med. 17:234–241.
   PubMed Web of Science ®Google Scholar
• Cohen JC, Horton JD, Hobbs HH. 2011. Human fatty liver disease: old questions and new insights. Science. 332:1519–1523.
   PubMed Web of Science ®Google Scholar
• Cole BK, Feaver RE, Wamhoff BR, Dash A. 2018. Non-alcoholic fatty liver disease (NAFLD) models in drug discovery. Expert Opin Drug Dis. 13:193–205.
   PubMed Web of Science ®Google Scholar
• Crowther JR. 2002. The ELISA Guidebook. Totowa, New Jersey: Humana Press. 149:1–413.
   Google Scholar
• Day CP, James OFW. 1998. Steatohepatitis: a tale of two "hits"? Gastroenterology. 114:842–845.
   PubMed Web of Science ®Google Scholar
• de Souza Mesquita LM, Caria CREP, Santos PS, Ruy CC, da Silva Lima N, Moreira DKT, da Rocha CQ, Murador DC, de Rosso VV, Gambero A, et al. 2018. Modulatory effect of polyphenolic compounds from the mangrove tree Rhizophora mangle L. on non-alcoholic fatty liver disease and insulin resistance in high-fat diet obese mice. Molecules. 23:9–14.
   Web of Science ®Google Scholar
• Dong H, Lu FE, Zhao L. 2012. Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease. Chin J Integr Med. 18:152–160.
   PubMed Web of Science ®Google Scholar
• Dong X, Fu J, Yin X, Yang C, Zhang X, Wang W, Du X, Wang Q, Ni J. 2017. Cassiae semen: a review of its phytochemistry and pharmacology (Review). Mol Med Rep. 16:2331–2346.
   PubMed Web of Science ®Google Scholar
• Fu F, Tian F, Zhou H, Lv W, Tie R, Ji L, Li R, Shi Z, Yu L, Liang X, et al. 2014. Semen Cassiae attenuates myocardial ischemia and reperfusion injury in high-fat diet streptozotocin-induced type 2 diabetic rats. Am J Chin Med. 42:95–108.
   PubMed Web of Science ®Google Scholar
• Go GW. 2015. Low-density lipoprotein receptor-related protein 6 (LRP6) is a novel nutritional therapeutic target for hyperlipidemia, non-alcoholic fatty liver disease, and atherosclerosis. Nutrients. 7:4453–4464.
   PubMed Web of Science ®Google Scholar
• He ZW, Wei W, Li SP, Ling Q, Liao KJ, Wang X. 2014. Anti-allodynic effects of obtusifolin and gluco-obtusifolin against inflammatory and neuropathic pain. Biol Pharm Bull. 37:1606–1616.
   PubMed Web of Science ®Google Scholar
• Ip FC, Zhao YM, Chan KW, Cheng EY, Tong EP, Chandrashekar O, Fu GM, Zhao ZZ, Ip NY. 2016. Neuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic rats. BMC Complement Altern Med. 16:437–441.
   PubMed Web of Science ®Google Scholar
• Ivaturi S, Wooten CJ, Nguyen MD, Ness GC, Lopez D. 2014. Distribution of the LDL receptor within clathrin-coated pits and caveolae in rat and human liver. Biochem Biophys Res Commun. 445:422–427.
   PubMed Web of Science ®Google Scholar
• Jin CH, Rhyu HS, Kim JY. 2018. The effects of combined aerobic and resistance training on inflammatory markers in obese men. J Exerc Rehabil. 14:660–665.
   PubMed Web of Science ®Google Scholar
• Ju MS, Kim HG, Choi JG, Ryu JH, Hur J, Kim YJ, Sook Oh M. 2010. Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models. Food Chem Toxicol. 48:2037–2044.
   PubMed Web of Science ®Google Scholar
• Jung HA, Ali MY, Jung HJ, Jeong HO, Chung HY, Choi JS. 2016. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases. J Ethnopharmacol. 191:152–160.
   PubMed Web of Science ®Google Scholar
• Ok DP, Ko K, Bae JY. 2018. Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits. Lipids Health Dis. 17:207–211.
   PubMed Web of Science ®Google Scholar
• Kim DH, Yoon BH, Kim YW, Lee S, Shin BY, Jung JW, Kim HJ, Lee YS, Choi JS, Kim SY, et al. 2007. The seed extract of Cassia obtusifolia ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice. J Pharmacol Sci. 105:82–93.
   PubMed Web of Science ®Google Scholar
• Kim YS, Jung DH, Sohn E, Lee YM, Kim CS, Kim JS. 2014. Extract of Cassiae semen attenuates diabetic nephropathy via inhibition of advanced glycation end products accumulation in streptozotocin-induced diabetic rats. Phytomedicine. 21:734–739.
   PubMed Web of Science ®Google Scholar
• Paudel P, Jung HA, Choi JS. 2018. Anthraquinone and naphthopyrone glycosides from Cassia obtusifolia seeds mediate hepatoprotection via Nrf2-mediated HO-1 activation and MAPK modulation. Arch Pharm Res. 41:677–689.
   PubMed Web of Science ®Google Scholar
• Koca-Caliskan U, Yilmaz I, Taslidere A, Yalcin FN, Aka C, Sekeroglu N. 2018. Cuscuta arvensis Beyr "Dodder": in vivo hepatoprotective effects against acetaminophen-induced hepatotoxicity in rats. J Med Food. 21:625–631.
   PubMed Web of Science ®Google Scholar
• Koga T, Sumiyoshi R, Kawakami A, Yoshizaki K. 2018. A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease. Mod Rheumatol. 4:1–9.
   Google Scholar
• Koo BK, Joo SK, Kim D, Bae JM, Park JH, Kim JH, Kim W. 2017. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease. J Gastroen Hepatol. 33:1155–1299.
   Web of Science ®Google Scholar
• Kwon KS, Lee JH, So KS, Park BK, Lim H, Choi JS, Kim HP. 2018. Aurantio-obtusin, an anthraquinone from cassiae semen, ameliorates lung inflammatory responses. Phytother Res. 32:1537–1545.
   PubMed Web of Science ®Google Scholar
• Liang L, Ma T, Chen W, Hu J, Bai X, Li J, Liang T. 2009. Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury. Hepatol Res. 39:822–832.
   PubMed Web of Science ®Google Scholar
• Liu YL, Patman GL, Leathart JB, Piguet AC, Burt AD, Dufour JF, Day CP, Daly AK, Reeves HL, Anstee QM. 2014. Carriage of the PNPLA3 rs738409 C > G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol. 61:75–81.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25:402–408.
   PubMed Web of Science ®Google Scholar
• Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi LE. 2017. Nonalcoholic fatty liver disease: evolving paradigms. World J Gastroenterol. 23:6571–6592.
   PubMed Web of Science ®Google Scholar
• López G, Bernal LM, Gelvez N, Gómez LF, Nova A, Sánchez AI, Tamayo ML. 2018. Mutational analysis of the LDLR gene in a cohort of Colombian families with familial hypercholesterolemia. Atherosclerosis. 277:434–439.
   PubMed Web of Science ®Google Scholar
• Magkos F, Fabbrini E, Korenblat K, Okunade AL, Patterson BW, Klein S. 2011. Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease. Int J Obes. 35:1233–1240.
   Web of Science ®Google Scholar
• Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, Lonardo A. 2013. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 59:859–871.
   PubMed Web of Science ®Google Scholar
• Rath MM, Panigrahi MK, Pattnaik K, Bhuyan P, Kar SK, Misra B, Misra D, Meher C, Agrawal O, Rath J, et al. 2016. Histological evaluation of non-alcoholic fatty liver disease and its correlation with different noninvasive scoring systems with special reference to fibrosis: A single center experience. J Clin Exp Hepatol. 6:291–296.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Schattenberg JM. 2013. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol. 28:68–76.
   PubMed Web of Science ®Google Scholar
• Tada H, Kawashiri MA, Nomura A, Teramoto R, Hosomichi K, Nohara A, Inazu A, Mabuchi H, Tajima A, Yamagishi M. 2018. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease. J Clin Lipidol. 18:30365–30369.
   Google Scholar
• Toldo S, Austin D, Mauro AG, Mezzaroma E, Van Tassell BW, Marchetti C, Carbone S, Mogelsvang S, Gelber C, Abbate A. 2017. Low-density lipoprotein receptor-related protein-1 is a therapeutic target in acute myocardial infarction. JACC Basic Transl Sci. 2:561–574.
   PubMedGoogle Scholar
• Tong Q, Wang XL, Li SB, Yang GL, Jin S, Gao ZY, Liu XB. 2018. Combined detection of IL-6 and IL-8 is beneficial to the diagnosis of early stage esophageal squamous cell cancer: a preliminary study based on the screening of serum markers using protein chips. OTT. 11:5777–5787.
   Web of Science ®Google Scholar
• Tsai E, Lee TP. 2018. Diagnosis and evaluation of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, including noninvasive biomarkers and transient elastography. Clin Liver Dis. 22:73–92.
   PubMed Web of Science ®Google Scholar
• Usifo E, Leigh SEA, Whittall RA, Lench N, Taylor A, Yeats C, Orengo CA, Martin ACR, Celli J, Humphries SE. 2012. Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment. Ann Hum Genet. 76:387–401.
   PubMed Web of Science ®Google Scholar
• Wang S, Song K, Srivastava R, Dong C, Go GW, Li N, Iwakiri Y, Mani A. 2015. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a. FASEB J. 29:3436–3445.
   PubMed Web of Science ®Google Scholar
• Wang X, Han L, Li G, Peng W, Gao X, Klaassen CD, Fan G, Zhang Y. 2018. Identification of natural products as inhibitors of human organic anion transporters (OAT1 and OAT3) and their protective effect on mercury-induced toxicity. Toxicol Sci. 161:321–334.
   PubMed Web of Science ®Google Scholar
• Wilkins T, Tadkod A, Hepburn I, Schade RR. 2013. Nonalcoholic fatty liver disease: diagnosis and management. Am Fam Physician. 88:35–42.
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H. 2016. Diagnosis of nonalcoholic fatty liver disease (NAFLD). Duodecim. 132:2099–2106.
   PubMedGoogle Scholar
• Yu D, Chen G, Pan M, Zhang J, He W, Liu Y, Nian X, Sheng L, Xu B. 2017. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4 alpha and leads to hepatic steatosis in mice. J Cell Physiol. 1:1–13.
   Google Scholar
• Zou LQ, Chen J, Pan L, Jiang JZ, Xing W. 2015. Comparison of magnetic resonance elastography and diffusion-weighted imaging for staginghepatic fibrosis. Chin Med J (Engl). 128:620–625.
   PubMed Web of Science ®Google Scholar